Clinical Trials Browser

Phase 2 × Breast Neoplasms × orteronel × Clear all

NCT01990209 2022-06-30

Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR)

Phase 2 Completed

71 enrolled 23 charts

Breast Neoplasms, Triple Negative Breast Neoplasms